Dirk Huebner, President
Professional Overview
Dirk Huebner is an accomplished executive with extensive experience in the biopharmaceutical industry. As the President of Aptevo Therapeutics Inc, he oversees the strategic direction and day-to-day operations of the company, driving innovation and growth in the development of novel therapeutic solutions. Concurrently, Dirk serves as a Consultant Chief Medical Officer at Exacis Biotherapeutics, where he leverages his deep expertise in oncology drug development to guide the company's clinical research efforts.
Experience Summary
Current Role
As the President of Aptevo Therapeutics Inc since 2021, Dirk is responsible for leading the company's strategic vision and ensuring the successful execution of its oncology and immunology drug development pipeline. Under his leadership, Aptevo has maintained a strong focus on advancing its proprietary ADAPTIR™ bispecific technology platform, which has produced multiple promising clinical-stage candidates. Dirk's strategic oversight and industry insights have been instrumental in positioning Aptevo as a leader in the development of innovative bispecific therapies.
Concurrently, Dirk serves as a Consultant Chief Medical Officer at Exacis Biotherapeutics, where he provides strategic guidance and medical expertise to support the company's ongoing clinical trials and regulatory submissions for its novel immunotherapies.
Career Progression
Prior to his current roles, Dirk held various senior leadership positions in the biopharmaceutical industry. He served as the Senior Medical Advisor at Mersana Therapeutics, the Chief Medical Officer at Mersana Therapeutics, the Vice President - Head of Development at Boston Biomedical, and the Executive Medical Director Oncology Clinical Research at Takeda Oncology. Throughout his career, Dirk has demonstrated a proven track record of driving the successful development and approval of oncology and immunology therapeutics, contributing to the advancement of several innovative drug candidates.
Academic Background
Dirk earned his medical degree from the University Hospital Eppendorf in Hamburg, Germany, where he also completed his medical residency in the Department of Urology. His extensive clinical and research experience, combined with his strategic leadership skills, have positioned him as a respected authority in the biopharmaceutical industry.
Areas of Expertise
- Oncology and immunology drug development
- Bispecific and novel therapeutic platform technologies
- Clinical trial design and execution
- Regulatory strategy and submissions
- Medical and scientific affairs
- Strategic planning and operations management
Professional Impact
Dirk's contributions to the biopharmaceutical industry have been recognized through his involvement in the development and approval of numerous oncology and immunology therapies. His leadership and expertise have been instrumental in advancing the clinical pipeline and driving the commercial success of the companies he has served. Dirk's commitment to innovation and patient-centric drug development has earned him a reputation as a respected industry leader.
Conclusion
With his extensive experience, proven track record of success, and deep understanding of the biopharmaceutical landscape, Dirk Huebner is well-positioned to continue driving innovation and growth in the industry. As the President of Aptevo Therapeutics and a Consultant Chief Medical Officer at Exacis Biotherapeutics, Dirk remains focused on advancing the development of novel, transformative therapies that have the potential to improve patient outcomes and address unmet medical needs.
